Niagen Bioscience Inc (NAGE)
NAGE Stock Price Chart
Explore Niagen Bioscience Inc interactive price chart. Choose custom timeframes to analyze NAGE price movements and trends.
NAGE Company Profile
Discover essential business fundamentals and corporate details for Niagen Bioscience Inc (NAGE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Jun 2015
Employees
104.00
Website
https://www.niagenbioscience.comCEO
Robert N. Fried
Description
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
NAGE Financial Timeline
Browse a chronological timeline of Niagen Bioscience Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $0.01, while revenue estimate is $32.18m.
Earnings released on 6 May 2026
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $31.47m , beating expectations by +1.43%.
Earnings released on 4 Mar 2026
EPS came in at $0.03 surpassing the estimated $0.02 by +50.00%, while revenue for the quarter reached $33.84m , beating expectations by +6.74%.
Earnings released on 4 Nov 2025
EPS came in at $0.05 surpassing the estimated $0.02 by +233.33%, while revenue for the quarter reached $33.99m , beating expectations by +9.27%.
Earnings released on 6 Aug 2025
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $31.12m , beating expectations by +1.15%.
Earnings released on 7 May 2025
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $30.48m , beating expectations by +12.58%.
Earnings released on 4 Mar 2025
EPS came in at $0.03 surpassing the estimated $0.02 by +50.00%, while revenue for the quarter reached $29.13m , beating expectations by +8.78%.
Earnings released on 31 Oct 2024
EPS came in at $0.02 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $25.58m , beating expectations by +6.44%.
Earnings released on 30 Jun 2024
EPS came in at -$0.00 surpassing the estimated -$0.02 by +99.00%, while revenue for the quarter reached $22.74m , missing expectations by -2.51%.
Earnings released on 8 May 2024
EPS came in at -$0.01 surpassing the estimated -$0.02 by +50.00%, while revenue for the quarter reached $22.15m , missing expectations by -5.63%.
Earnings released on 6 Mar 2024
EPS came in at $0.00 surpassing the estimated -$0.03 by +105.82%, while revenue for the quarter reached $21.20m , beating expectations by +1.84%.
Earnings released on 8 Nov 2023
EPS came in at $0.00 surpassing the estimated -$0.03 by +116.27%, while revenue for the quarter reached $19.50m , missing expectations by -3.95%.
Earnings released on 9 Aug 2023
EPS came in at -$0.03 surpassing the estimated -$0.04 by +25.00%, while revenue for the quarter reached $20.32m , beating expectations by +4.66%.
Earnings released on 10 May 2023
EPS came in at -$0.03 surpassing the estimated -$0.05 by +35.59%, while revenue for the quarter reached $22.56m , beating expectations by +16.24%.
NAGE Stock Performance
Access detailed NAGE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
